| 87.675 2.755 (3.24%) | 05-05 11:32 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 105.28 | 1-year : | 114.81 |
| Resists | First : | 90.14 | Second : | 98.3 |
| Pivot price | 88.53  |
|||
| Supports | First : | 76.94 | Second : | 64.02 |
| MAs | MA(5) : | 85.2 |
MA(20) : | 90.06 |
| MA(100) : | 97.24 |
MA(250) : | 80.08 |
|
| MACD | MACD : | -3.1 |
Signal : | -3 |
| %K %D | K(14,3) : | 52 |
D(3) : | 38 |
| RSI | RSI(14): 40.4 |
|||
| 52-week | High : | 107.69 | Low : | 49.87 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IRMD ] has closed above bottom band by 37.1%. Bollinger Bands are 54.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 87.53 - 88.01 | 88.01 - 88.41 |
| Low: | 82.89 - 83.57 | 83.57 - 84.12 |
| Close: | 83.92 - 84.93 | 84.93 - 85.75 |
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Tue, 05 May 2026
IRadimed Corporation (NASDAQ:IRMD) Q1 2026 Earnings Call Transcript - Insider Monkey
Tue, 05 May 2026
IRadimed declares $0.20 dividend - MSN
Mon, 04 May 2026
Is IRADIMED’s 3870 Pump Launch And Reaffirmed Outlook Altering The Investment Case For IRMD? - simplywall.st
Sat, 02 May 2026
IRADIMED (IRMD) Revenue Growth Track Tests Bullish MRI Demand Narratives - Sahm
Fri, 01 May 2026
Earnings call transcript: Iradimed Co beats Q1 2026 expectations, stock dips - Investing.com
Fri, 01 May 2026
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 13 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 36.6 (%) |
| Held by Institutions | 59.9 (%) |
| Shares Short | 540 (K) |
| Shares Short P.Month | 492 (K) |
| EPS | 1.83 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.4 |
| Profit Margin | 26.8 % |
| Operating Margin | 31.2 % |
| Return on Assets (ttm) | 15.7 % |
| Return on Equity (ttm) | 24.7 % |
| Qtrly Rev. Growth | 17 % |
| Gross Profit (p.s.) | 5.03 |
| Sales Per Share | 6.55 |
| EBITDA (p.s.) | 2.13 |
| Qtrly Earnings Growth | 24.7 % |
| Operating Cash Flow | 25 (M) |
| Levered Free Cash Flow | 7 (M) |
| PE Ratio | 47.44 |
| PEG Ratio | 0 |
| Price to Book value | 11.73 |
| Price to Sales | 13.24 |
| Price to Cash Flow | 44.47 |
| Dividend | 0.2 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|